PTEN mutations may overlap with other mutations, including human epidermal growth factor receptor 2 (HER2) and loss of a single PTEN allele has been shown to accelerate tumorigenesis in HER2-overexpressing breast tumors [30]. This evidence concerns the gene ERBB2 and breast neoplasm.